News
Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...
RSV infection model could shed light on viral transmission and pathogenesis Feb. 22, 2024 Researchers from the Peking University Health Science Center have developed a murine model of RSV infection ...
Doctors say RSV trends are returning to pre-pandemic levels. Some hospitals in the U.S. are seeing an increase in RSV and higher levels of "walking pneumonia" among young children despite overall ...
In September, an 8-month-old baby came into Dr. Juanita Mora’s office in Chicago with an infection the doctor hadn’t expected to see for another two months: RSV. Like her peers across the ...
Cases of covid, flu and RSV are colliding, keeping kids home from school, straining hospital systems and prompting worries about a potential “tripledemic.” Cases of respiratory syncytial virus ...
RSV is ubiquitous. Nearly everyone has been infected with the virus before age 2, the US Centers for Disease Control and Prevention says. Infection usually causes symptoms that look a lot like a ...
According to health officials, RSV cases among pediatric patients recently increased in at least 33 states. "The reason we are seeing a big surge now is during the pandemic we were masking ...
As people confront the cold and flu season, what’s top of mind for many Californians this year is the unseasonably early activity of respiratory syncytial virus, or RSV, which causes a ...
You can get RSV more than once in your lifetime. In fact, you’re likely to get it multiple times throughout your life. You can even get RSV twice in the same season. But later infections tend to ...
Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and Drug Administration is reportedly expediting its review approval process. The FDA is expected to make their ...
Nirsevimab, a new shot given as one dose in the first or second RSV season, was recently recommended by the CDC for all infants younger than 8 months old to prevent complications from respiratory ...
"I don't think I can say it enough, but [we need] more studies in moderate-to-severe immunocompromised patients who are at highest risk for RSV disease," ACIP member Mini Kamboj, MD, of Weill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results